Breadcrumb
  1. Home
  2. Data & Reporting
  3. Health Center COVID-19 Survey
  4. Georgia Health Center COVID-19 Survey Summary Report

Georgia Health Center COVID-19 Survey Summary Report

Latest data from June 17, 2022

Number of Health Center respondents = 26 (74% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 3,928
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 53.89%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 755
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 55.60%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 45.26% 43.58%
White, Hispanic/Latino Patients 8.27% 6.23%
Black/African American, Non-Hispanic/Latino Patients 38.47% 44.37%
Black/African American, Hispanic/Latino Patients 1.15% 0.66%
Asian Patients3 1.04% 1.19%
American Indian/Alaska Native Patients3 0.56% 0.26%
Native Hawaiian/Other Pacific Islander Patients3 0.10% 0.00%
Patients with More Than One Race3 1.96% 1.19%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.35% 0.66%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.09% 0.93%
Unreported/Refused to Report Race and Ethnicity 0.74% 0.93%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 181
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 82.49%
COVID-19 Immunization Series Completed 196
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 85.57%
COVID-19 Immunization Series Additional 490
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 76.29%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 17.13% 14.29% 23.47%
White, Hispanic/Latino Patients 9.94% 15.31% 8.78%
Black/African American, Non-Hispanic/Latino Patients 66.30% 66.84% 62.24%
Black/African American, Hispanic/Latino Patients 0.55% 2.55% 1.22%
Asian Patients3 2.21% -2.55% 1.02%
American Indian/Alaska Native Patients3 0.00% 0.00% 1.63%
Native Hawaiian/Other Pacific Islander Patients3 1.10% 0.00% 0.00%
Patients with More Than One Race3 0.55% 2.04% 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.00% 0.51% 0.61%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.55% 1.02% 0.20%
Unreported/Refused to Report Race and Ethnicity 1.66% 0.00% 0.82%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 23.08%
1 to 24 Hours 42.31%
More Than 24 Hours 30.77%
N/A 3.85%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 26.92%
Vaccine confidence 34.62%
Vaccine storage capacity 3.85%
Vaccine supply 0.00%
Other 3.85%
None 34.62%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 34.62%
Average Percent of Health Center Visits Conducted Virtually 6.73%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 38.46%
Number of Mobile Van Sites 10
Number of Pop-up Clinics 3
Number of School-Based Vaccination Sites 4
Number of Family Vaccination Clinics 12

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 3.85%
Refer patients to another organization that provides monoclonal antibody therapies 57.69%
None 38.46%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 7.69%
Patient awareness/education 7.69%
Staffing capacity 19.23%
Therapy administration/onsite logistics 3.85%
Other 11.54%
None 61.54%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 13
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 3,402

Test Kit Distribution Methods4

Metrics Value
Provided to Existing Health Center Patients 69.23%
Provided to General Public Who Came to the Health Center 46.15%
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 15.38%
Provided at Other Community Events 38.46%
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals 15.38%
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals 23.08%
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals 15.38%
Provided to school-age children and/or their families directly or through partnerships with schools 15.38%
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities 7.69%
Other 15.38%

N95 Mask Distribution

Metrics Value
Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program 12
Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program 3,044

N95 Mask Distribution Methods5

Metrics Value
Provided to Existing Health Center Patients 83.33%
Provided to General Public Who Came to the Health Center 33.33%
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 16.67%
Provided at Other Community Events 33.33%
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals 16.67%
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals 16.67%
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals 16.67%
Provided to school-age children and/or their families directly or through partnerships with schools 8.33%
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities 8.33%
Other 0.00%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 2
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication 81.82%

Oral Antiviral Medication Distribution by Race and Ethnicity

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients 18.18%
White, Hispanic/Latino Patients 36.36%
Black/African American, Non-Hispanic/Latino Patients 36.36%
Black/African American, Hispanic/Latino Patients 0.00%
Asian Patients3 0.00%
American Indian/Alaska Native Patients3 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.00%
Patients with More Than One Race3 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 9.09%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.00%
Unreported/Refused to Report Race and Ethnicity 0.00%

Oral Antiviral Medication Distribution by Population Type

Metrics Value
Migratory/Agricultural Workers 0.00%
Patients Experiencing Homelessness 0.00%
Patients Who Are Residents of Public Housing 0.00%
Patients with Limited English Proficiency 45.45%
Children Under 18 Years of Age 0.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.

Date Last Reviewed: